Oramed Pharmaceuticals Inc (ORMP)
2.36
+0.05
(+2.16%)
USD |
NASDAQ |
Nov 22, 10:11
Oramed Pharmaceuticals Price to Book Value: 0.6081 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 0.5952 |
| November 20, 2024 | 0.5824 |
| November 19, 2024 | 0.5927 |
| November 18, 2024 | 0.5592 |
| November 15, 2024 | 0.5746 |
| November 14, 2024 | 0.6017 |
| November 13, 2024 | 0.5978 |
| November 12, 2024 | 0.603 |
| November 11, 2024 | 0.5978 |
| November 08, 2024 | 0.5952 |
| November 07, 2024 | 0.6133 |
| November 06, 2024 | 0.6014 |
| November 05, 2024 | 0.604 |
| November 04, 2024 | 0.6143 |
| November 01, 2024 | 0.5963 |
| October 31, 2024 | 0.6117 |
| October 30, 2024 | 0.6194 |
| October 29, 2024 | 0.5886 |
| October 28, 2024 | 0.5963 |
| October 25, 2024 | 0.6079 |
| October 24, 2024 | 0.6066 |
| October 23, 2024 | 0.6117 |
| October 22, 2024 | 0.6092 |
| October 21, 2024 | 0.6027 |
| October 18, 2024 | 0.595 |
| Date | Value |
|---|---|
| October 17, 2024 | 0.6169 |
| October 16, 2024 | 0.6246 |
| October 15, 2024 | 0.604 |
| October 14, 2024 | 0.6117 |
| October 11, 2024 | 0.6117 |
| October 10, 2024 | 0.6104 |
| October 09, 2024 | 0.6169 |
| October 08, 2024 | 0.5989 |
| October 07, 2024 | 0.6194 |
| October 04, 2024 | 0.604 |
| October 03, 2024 | 0.6194 |
| October 02, 2024 | 0.6143 |
| October 01, 2024 | 0.6169 |
| September 30, 2024 | 0.6271 |
| September 27, 2024 | 0.571 |
| September 26, 2024 | 0.5526 |
| September 25, 2024 | 0.5503 |
| September 24, 2024 | 0.5411 |
| September 23, 2024 | 0.5353 |
| September 20, 2024 | 0.5319 |
| September 19, 2024 | 0.5687 |
| September 18, 2024 | 0.5572 |
| September 17, 2024 | 0.5779 |
| September 16, 2024 | 0.571 |
| September 13, 2024 | 0.5733 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4619
Minimum
Nov 01 2023
11.80
Maximum
Feb 17 2021
2.725
Average
1.995
Median
Sep 16 2020
Price to Book Value Benchmarks
| Skye Bioscience Inc | 1.673 |
| Scilex Holding Co | -- |
| NovaBay Pharmaceuticals Inc | 3.213 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.314 |
Price to Book Value Related Metrics
| PE Ratio | 21.45 |
| PS Ratio | 36.14 |
| Price | 2.36 |
| Earnings Yield | 4.66% |
| Market Cap | 95.14M |